Aeglea Biotherapeutics shares owned by Driehaus Capital Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Driehaus Capital Management
from 13F filings
Historical chart of Driehaus Capital Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Driehaus Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Aeglea Biotherapeutics by Driehaus Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-09-30 | $9.8M | 801k | 12.25 |
More positions owned by Driehaus Capital Management
View all positions for Driehaus Capital Management